5.0
Sep 19, 2025
Former employee, more than 3 years
Cambridge, MA
Recommend
CEO approval
Business outlook
Pros
transparency embraced corporate values of fellowship and humility great people and teams
Cons
no longer operating despite success in running clinical trials with complex cell therapies, ran out of runway, couldn't raise money in poor biotech environment